In a recent meta-analysis which included individual-patient data from five randomized trials, beta-blocker therapy did not ...

Coronary artery disease is one of the leading causes of morbidity and mortality worldwide. Although it can present with an ...

A collaborative effort among international research teams provides the most definitive statement yet on the usefulness of ...

The original paper, ‘CXCR4 PET/CT Predicts Left Ventricular Recovery 8 Months After Acute Myocardial Infarction,’ can be found here: ...

Nearly half of adults with a first myocardial infarction show low or borderline risk on current risk estimators. Most develop ...

A study published in BMC Nephrology explored whether serum angiotensinogen could serve as a reliable biomarker to identify ...

Non-ST elevation myocardial infarction (NSTEMI) represents a significant clinical entity within the spectrum of acute ...

Background Percutaneous ventricular assist devices (pVAD) have been increasingly used to support haemodynamics during ...

In this paper by Attar and colleagues (BMJ 2025;391:e083382, doi:10.1136/bmj-2024-083382, published 29 October 2025), The BMJ was alerted to post-publication ...

The association between air pressure and acute myocardial infarction (AMI) has not been assessed at individual level, and the effect of air pressure change between neighboring days (APCN) on AMI onset ...

Cardiogenic shock (CS) following acute myocardial infarction (AMI) remains one of cardiology’s most formidable challenges, carrying a mortality rate that stubbornly persists around 40–50% despite ...

Compared with crushed ticagrelor, intravenous (IV) cangrelor provided immediate and effective platelet inhibition with no increase in major bleeding and lower mortality rates in patients with acute ...